Please login to the form below

Not currently logged in
Email:
Password:

bacterial resistance

This page shows the latest bacterial resistance news and features for those working in and with pharma, biotech and healthcare.

Longitude Prize in final stage of deciding recipients of £8m prize

Longitude Prize in final stage of deciding recipients of £8m prize

The test will help to support treatment decisions, reduce overuse of antibiotics and confront the rising issue of antimicrobial resistance (AMR). ... AMR poses a critical threat to the world’s population – in 2019, more than 1.2 million people

Latest news

  • GSK takes new-class antibiotic into phase 3 for serious infections GSK takes new-class antibiotic into phase 3 for serious infections

    Because it works in a different way to any currently-approved antibiotic, gepotidacin could sidestep bacterial resistance mechanisms. ... EAGLE-1 will compare gepotidacin – a triazaacenaphthylene bacterial topoisomerase inhibitor developed in

  • Motif Bio preps US filing after antibiotic clears phase III Motif Bio preps US filing after antibiotic clears phase III

    resistance to other antibiotics, including ‘superbugs’ such as methicillin resistant Staphylococcus aureus (MRSA). ... There is an urgent need for new antibiotics to counter the rising threat of antimicrobial resistance.

  • Longitude Prize awards grants for antibiotic test development Longitude Prize awards grants for antibiotic test development

    they are all working towards one goal - the development of a tool which will radically transform the way people access antibiotics and help to fight the growing threat of antibiotic resistance.”. ... The Longitude committee, along with partner Innovate

  • Merck starts pivotal trials of new antibiotic combination Merck starts pivotal trials of new antibiotic combination

    In some cases, carbapenems are the last-line therapy for MDR infections, but there has been a progressive increase in resistance to the class in bacterial families such as the Enterobacteriaceae, ... The first is comparing treatment with

  • CHMP backs AZ's 'superbug' antibiotic product CHMP backs AZ's 'superbug' antibiotic product

    The Committee for Medicinal Products for Human Use (CHMP) recommended approval of Zavicefta (ceftazidime/avibactam), which combines an established antibiotic with a new drug designed to overcome bacterial resistance. ... AZ notes that in Europe,

More from news
Approximately 1 fully matching, plus 16 partially matching documents found.

Latest Intelligence

  • Tackling antimicrobial resistance on multiple fronts Tackling antimicrobial resistance on multiple fronts

    With an estimated 25, 000 deaths in Europe alone and one person dying every 15 minutes in the US because of drug-resistant bacterial infections, antimicrobial resistance (AMR) is undoubtedly one ... latest World Bank report, Pulling Together to Beat

  • The impending threat of antibiotic resistance The impending threat of antibiotic resistance

    The frequency of antibiotic resistance in a bacterial culture is in the order of one antibiotic resistant mutation in 100 million bacteria. ... Combining two existing antibiotics to see if they can overcome antibiotic resistance or.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Create Health

A specialist Advertising and Med Comms agency dedicated to bringing much-needed creativity to healthcare marketing. We believe that brilliant ideas...

Latest intelligence

Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...
Animation: Living With
The journey from the patient's perspective...